2.3.6 Acute and Postherpetic Neuralgia
Varicella-zoster virus infection or reactivation ("shingles") is more likely to
occur in patients with cancer than in the general population because of the
higher incidence of immunosuppression in the former. Zoster neuralgia may cause
acute and chronic pain (Rusthoven, Ahlgren, Elhakim, et al., 1988).
Disseminated zoster is twice as likely to occur in patients with progressive
tumor than those in remission (Rusthoven, Ahlgren, Elhakim, et al., 1988).
Thoracic and cranial dermatomes are most commonly affected, and the incidence
of postherpetic neuralgia (pain after healing of rash) increases with age
(Watson, Evans, Reed, et al., 1982).
Varicella-zoster virus infection is characterized by a burning, aching pain.
Lancinating or shocklike pain may be superimposed in the area of the crusted
(or healed) hermetic skin lesions, in which there is usually sensory loss.
Hyperpathia may be profound. For acute foster, antiviral therapies in
combination with analgesics are recommended. For postherpetic neuralgia,
antiviral therapies are of limited use, and therapies for neuropathic pain are
used (see Chapter 3). Empiric observations suggest that nerve blocks during
acute herpes foster infection reduce pain, shorten the acute episode, and
prevent the emergence of postherpetic neuralgia (Bonica, 1990). Treatment
approaches for neuropathic pain are discussed later (see also Figure 1).
Abdominal Pain
Physical Modalities
Counterstimulation
TENS
Introduction (Invasive nonpharmacologic interventions)
Radiation Therapy
Other Therapeutic Applications
Medical Interventions
Index